Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0
National Institutes of Health
Classification and identifiers
- Solicitation number
- RFA-AR-26-006
- Assistance listing (CFDA)
- 93.846
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), in conjunction with other NIH Institutes and Centers (ICs) as a part of the congressionally mandated NIH Helping to End Addiction Long Term (HEAL) initiative intends to publish a Notice of Funding Opportunity (NOFO) to leverage and accelerate the progress achieved in the Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium. The NOFO aims to more fully refine and map the innervation of the different articular and peri-articular tissues that collectively form the joint (including bone, cartilage, synovium, joint capsule, ligament, tendon, fascia and muscle), by sensory neurons that mediate the sensation of pain. The NOFO seeks to expand initial and ongoing efforts by: Enhancing clinical pain...
Related opportunities
- HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)National Institutes of HealthCloses in 10 daysUp to $100K
- A Holistic Approach to Study Non-Addictive Natural Products for Pain ManagementNational Institutes of Health
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin DiseasesNational Institutes of HealthUp to $600K
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2027Up to $350K
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)National Institutes of HealthCloses Nov 2026Up to $375K
- Improving Chronic Conditions Through Inexpensive InterventionsNational Institutes of Health